The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial
Open accessAbstract
OBJECTIVE: To examine in a randomised trial whether a 25% difference in mortality exists between 4.5 months and 3 years of age for children given two standard doses of Edmonston-Zagreb measles vaccines at 4.5 and 9 months of age compared with those given one dose of measles vaccine at 9 months of age (current policy). DESIGN: Randomised controlled trial. SETTING: The Bandim Health Project, Guinea-Bissau, which maintains a health and demographic surveillance system in an urban area. PARTICIPANTS: 6648 children aged 4.5 months of age who had received three doses of diphtheria-tetanus-pertussis vaccine at least four weeks before enrolment. A large proportion of the children (80%) had previously taken part in randomised trials of neonatal vitamin A supplementation. INTERVENTION: Children were randomised to receive Edmonston-Zagreb measles vaccine at 4.5 and 9 months of age (group A), no vaccine at 4.5 months and Edmonston-Zagreb measles vaccine at 9 months of age (group B), or no vaccine at 4.5 months and Schwarz measles vaccine at 9 months of age (group C). Main outcome measure Mortality rate ratio between 4.5 and 36 months of age for group A compared with groups B and C. Secondary outcomes tested the hypothesis that the beneficial effect was stronger in the 4.5 to 9 months age group, in girls, and in the dry season, but the study was not powered to test whether effects differed significantly between subgroups. RESULTS: In the intention to treat analysis of mortality between 4.5 and 36 months of age the mortality rate ratio of children who received two doses of Edmonston-Zagreb vaccine at 4.5 and 9 months of age compared with those who received a single dose of Edmonston-Zagreb vaccine or Schwarz vaccine at 9 months of age was 0.78 (95% confidence interval 0.59 to 1.05). In the analyses of secondary outcomes, the intention to treat mortality rate ratio was 0.67 (0.38 to 1.19) between 4.5 and 9 months and 0.83 (0.83 to 1.16) between 9 and 36 months of age. The effect on mortality between 4.5 and 36 months of age was significant for girls (intention to treat mortality rate ratio 0.64 (0.42 to 0.98)), although this was not significantly different from the effect in boys (0.95 (0.64 to 1.42)) (interaction test, P=0.18). The effect did not differ between the dry season and the rainy season. As neonatal vitamin A supplementation is not WHO policy, the analyses were done separately for the 3402 children who did not receive neonatal vitamin A. In these children, the two dose Edmonston-Zagreb measles vaccine schedule was associated with a significantly lower mortality between 4.5 and 36 months of age (intention to treat mortality rate ratio 0.59 (0.39 to 0.89)). The effect was again significant for girls but not statistically significant from the effect in boys. When measles cases were censored, the intention to treat mortality rate ratio was 0.65 (0.43 to 0.99). CONCLUSIONS: Although the overall effect did not reach statistical significance, the results may indicate that a two dose schedule with Edmonston-Zagreb measles vaccine given at 4.5 and 9 months of age has beneficial non-specific effects on children's survival, particularly for girls and for children who have not received neonatal vitamin A. This should be tested in future studies in different locations. TRIAL REGISTRATION: Clinical trials NCT00168558.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No one is naive: the significance of heterologous T-cell immunity
Welsh, R. M., & Selin, L. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri820 · Cited by 463
Graham, B. S., Henderson, G. S., Tang, Y. W., Lu, X., Neuzil, K. M., & Colley, D. G. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2032 · Cited by 396
Aaby, P., Samb, B., Simondon, F., Seck, A. M. C., Knudsen, K., & Whittle, H. (1995) · BMJ · doi:10.1136/bmj.311.7003.481 · Cited by 344
Self-citationAdjuvant modulation of immune responses to tuberculosis subunit vaccines
Lindblad, E. B., Elhay, M. J., Silva, R., Appelberg, R., & Andersen, P. (1997) · Infection and Immunity · doi:10.1128/iai.65.2.623-629.1997 · Cited by 238
Aaby, P., Jensen, H., Samb, B., Cisse, B., Sodemann, M., Jakobsen, M., Poulsen, A., Rodrigues, A., Lisse, I. M., Simondon, F., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13771-3 · Cited by 203
Self-citationMoran, T. M., Park, H., Fernández-Sesma, A., & Schulman, J. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314952 · Cited by 136
Benn, C. S., Diness, B. R., Roth, A., Nante, E., Fisker, A. B., Lisse, I. M., Yazdanbakhsh, M., Whittle, H. C., Rodrigues, A., & Aaby, P. (2008) · BMJ · doi:10.1136/bmj.39542.509444.ae · Cited by 119
Self-citationImpact of measles vaccination on childhood mortality in rural Bangladesh.
Koenig, M., Khan, M. A., Wojtyniak, B., Clemens, J. D., Chakraborty, J., Fauveau, V., Phillips, J. F., Akbar, J., & Barua, U. (1990) · Europe PMC (PubMed Central) · Cited by 117
Measles vaccination and reduction in child mortality: A community study from Guinea-Bissau
Aaby, P., Bukh, J., Lisse, I. M., & Smits, A. J. (1984) · Journal of Infection · doi:10.1016/s0163-4453(84)93192-x · Cited by 117
Self-citationAaby, P., Bhuiya, A., Nahar, L., Knudsen, K. M., de Francisco, A., & Strong, M. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg005 · Cited by 117
Self-citation
Cited by
Defining trained immunity and its role in health and disease
Netea, M. G., Domínguez-Andrés, J., Barreiro, L. B., Chavakis, T., Divangahi, M., Fuchs, E., Joosten, L. A. B., van der Meer, J. W. M., Mhlanga, M. M., Mulder, W. J. M., et al. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0285-6 · Cited by 2,690
Aaby, P., Roth, A., Ravn, H., Napirna, B. M., Rodrigues, A., Lisse, I. M., Stensballe, L., Diness, B. R., Lausch, K. R., Lund, N., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir240 · Cited by 583
Self-citationA small jab – a big effect: nonspecific immunomodulation by vaccines
Benn, C. S., Netea, M. G., Selin, L. K., & Aaby, P. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.004 · Cited by 514
Self-citationVirus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults
Su, L. F., Kidd, B. A., Han, A., Kotzin, J. J., & Davis, M. M. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.021 · Cited by 429
“Consistent with these observations is the result of a randomized control trial involving over 6,000 children; it also showed a vaccine-dependent mortality reduction that was independent of measles-related death (Aaby et al., 2010).”
ResultSex Differences in Pediatric Infectious Diseases
Muenchhoff, M., & Goulder, P. J. R. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu232 · Cited by 406
Metadata
- Authors
- Aaby, P., Martins, C. L., Garly, M.-L., Bale, C., Andersen, A., Rodrigues, A., Ravn, H., Lisse, I. M., Benn, C. S., & Whittle, H. C.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2010-11-30
- Volume
- 341
- Issue
- nov30 2
- Pages
- c6495-c6495
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2142085660
- Cited by
- 283
- References
- 46
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. https://app.cochat.ai/papers/10.1136/bmj.c6495
- The paper
- Aaby, P., Martins, C. L., Garly, M.-L., Bale, C., Andersen, A., Rodrigues, A., Ravn, H., Lisse, I. M., Benn, C. S., & Whittle, H. C. (2010). Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ. https://doi.org/10.1136/bmj.c6495
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.